A new report published in The Lancet Diabetes & Endocrinology challenges the conventional definition of obesity, and urges a shift from the reliance on Body Mass Index (BMI) to a more nuanced approach. This is supported by over 50 global medical experts. The report also recommends splitting the term "obesity" into two categories: "Clinical obesity" and "Pre-clinical obesity". This aims to improve diagnosis and treatment for over a billion people worldwide living with obesity.
This applies to individuals whose obesity has progressed to a disease state, manifesting in organ damage, heart disease, type 2 diabetes, or other health complications. These individuals could also experience symptoms like breathlessness, joint pain, or impaired daily functioning. Treatment also involves medical interventions, including weight-loss medications or surgery.
Whereas the term "pre-clinic obese" refers to those who are overweight but not yet exhibiting health issues. While they may be at risk of developing obesity-related conditions, their organ function and overall health remain intact. What they need is preventive care, which includes dietary guidance, counselling, and regular monitoring to avoid and reduce future health risks.
The study, led by Professor Francesco Rubino from King's College London emphasizes that obesity is not one-size-fits-all condition. This means it should rather be treated as a spectrum as some individuals maintain normal organ function despite being classified as obese. There are others who may face severe health complications too. However, the current method of calculating obesity based on BMI often leads to misdiagnosis or inadequate care.
The report also states that BMI, while is useful for analyzing population trends, is a flawed unit of measuring individual health. Therefore, there is a need to redefine obesity, and healthcare professionals can provide more precise care by distinguishing those who need immediate medical intervention and those who require preventive strategies.
BMI is used to classify individuals as underweight, healthy weight, overweight, or obese based on their height and weight. It is calculated by dividing weight in kilograms by health in meters squared. However, there are reasons while it falls short.
•Muscle vs Fat: Athletes or muscular individuals often have high BMIs despite the low body fat
•Fat Distribution: BMI does not measure fat around the waist or organs, which could be more dangerous to one's health.
•Individual Health Variation: It also overlooks the specific health conditions such as heart diseases or diabetes, or any other, while evaluating a person's category in terms of weight.
ALSO READ: Is It Time To Say Goodbye To BMI?
By redefining obesity, the study could transform the approach to diagnosis and treatment. It can focus on individual health risks rather than BMI alone. Healthcare providers can also offer tailored care. This also will ensure hat weight-loss medications like Wegovy or Mounjaro are prescribed only to those who genuinely require it.
As per Professor Louise Baur from the University of Sydney, a Children's obesity expert said that this redefinition allows both adults and children to receive more appropriate care while reducing over-diagnosis and unnecessary treatments.
Credit: AI image
Women's bodies have long been understudied, and even a simple touch can trigger unexpected sadness, anguish or homesickness. One such experience is Sad Nipple Syndrome (SNS), which many women may experience without knowing it has a name. Triggered by nipple stimulation, it remains poorly understood and largely unresearched.
Some describe it as sudden sadness or anguish, while others compare it to homesickness, nostalgia or an upsetting memory. Even putting on a shirt can trigger the sensation.
SNS is not an officially recognised medical diagnosis. Although it can affect anyone, it appears more common in women, according to the Cleveland Clinic.
Also read: Lessons From The Lindsay Clancy Case: Can Families Spot Early Signs Of Postpartum Psychosis?
Some people experience SNS from childhood without understanding what is happening.
“I was probably a child when I first noticed: ‘Why does touching my nipple make me sad?’” 28-year-old Sandra told The Guardian.
She kept the experience to herself until college, when she searched for answers online. “I realized I wasn’t crazy,” she said.
One possible explanation involves oxytocin, commonly known as the 'love hormone'.
Dr Vladimír Kraus from the Department of Gynaecology and Obstetrics at Pavol Jozef Šafárik University suggests oxytocin may be involved because nipple stimulation triggers its release.
Oxytocin plays a role in bonding and emotional connection. It is released during physical touch and also plays a role in childbirth and breastfeeding.
Kraus theorises that changes in oxytocin signalling could trigger negative emotions associated with SNS, although this has not been established.
A study found that breast stimulation increased oxytocin levels in both lactating and non-lactating women, suggesting the response is not limited to breastfeeding.
Maureen Sweeney, a psychiatric mental health nurse practitioner and women's behavioural health specialist at the Cleveland Clinic, suggests oxytocin release may also influence dopamine production. Reduced dopamine could contribute to dysphoric feelings, although this remains a proposed explanation.
Other possible factors include postpartum mental health, body image concerns, anxiety and intimate partner violence. Sweeney also points to premenstrual dysphoric disorder (PMDD), suggesting that some people may be more sensitive to normal hormonal fluctuations.
Read More: Breastfeeding Can Help Reduce Mothers' Risk of Type 2 Diabetes, Breast Cancer and More
Dysphoric milk ejection reflex (D-MER) causes sudden negative emotions, such as sadness, homesickness and guilt, just before or during milk letdown while breastfeeding. It can also affect the breastfeeding experience and maternal bonding.Post-coital dysphoria (PCD), meanwhile, involves sadness, anxiety or irritability after sexual activity.
While SNS and D-MER are associated with nipple stimulation, PCD occurs after orgasm. Despite the different triggers, people can experience similar emotional and physical sensations, lactation consultant Alia Macrina Heise was quoted as saying to The Guardian.
She suggested hormonal interactions may be involved in all three conditions, although their precise mechanisms remain unclear.
There are no specific treatments for SNS, and more research is needed to understand its causes. However, coping strategies and psychological support may help manage the distress. Sweeney suggests cognitive behavioural therapy (CBT) as one approach to addressing symptoms, even when a therapist is unfamiliar with SNS.
Credit: AI
Per- and polyfluoroalkyl substances (PFAS), commonly known as forever chemicals, have sparked interests of epidemiologists who are investigating their links to chronic diseases like high blood pressure, cardiovascular conditions and certain cancers.
PFAS are a large group of chemicals made by humans that have been used in industrial processes and everyday consumer products. They are found in cosmetics, kitchen supplies, clothing, carpets, upholstery, food packaging and other household materials.
They are called forever chemicals because their strong chemical bonds make them resistant to breaking down in the environment. Some PFAS can also exist in the human body, allowing exposure to accumulate over time.
At the American Public Health Association's (APHA) 2026 Annual Meeting, researchers presented findings on how people are exposed to these chemicals everyday through food and drinking water, and what long-term health consequences may be related to that exposure.
Some studies have identified that PFAS exposure could lead to colon and liver cancers, low birth weight, development problems in children, complications during pregnancy and other metabolic disorders. Research has also identified its exposure to cholesterol, changes in liver enzymes, reduced antibody responses to some vaccines and hypertension during pregnancy.
However, this does not establish that PFAS exposure directly causes every condition reported in epidemiological studies. Health effects may depend on the chemical type, exposure levels, duration of exposure and individual factors.
The US Agency for Toxic Substances and Disease Registry (ATSDR) states that research into PFAS health effects is in progress.
Also read: Paper Straws Have 6.33 Times Higher Carcinogenic Risk Than Plastic Straws, Study Finds
Besides drinking water, food can also contribute to exposure, prompting researchers to investigate whether dietary habits influence the relationship between PFAS and chronic health conditions.
One study conducted in Massachusetts examined the relationship between dietary patterns, PFAS exposure and blood pressure. Researchers found stronger associations between a specific PFAS compound and high blood pressure among people who regularly consumed fish.
Yuting Wang, a postdoctoral research fellow at Silent Spring Institute and one of the researchers involved in the study, said animal-based foods appeared to contain more PFAS than plant-based foods.
One possible explanation, she suggested, was that meat consumption could increase inflammation, which may influence the relationship between PFAS exposure and blood pressure.
"Better understanding interactions among diet, PFAS and blood pressure may improve clinical recommendations to prevent hypertension," Wang said. "Future studies should account for exposure to environmental pollutants in addition to nutrient benefits of certain food," she added.
According to the US Geological Survey, approximately 45% of drinking water samples collected across the country showed traces of PFAS. Researchers have also investigated PFAS contamination in 11 townships in southeastern Pennsylvania. Their testing found that several drinking water supplies had PFAS concentrations exceeding the US Environmental Protection Agency's 2021 regulatory limits.
The team also examined two decades of mortality data from the townships to investigate whether areas with higher PFAS levels in public drinking water has different patterns of disease and death.
Erin Kulick, an assistant professor of epidemiology and biostatistics at Temple University College of Public Health who worked on the Pennsylvania study, said, "Southeastern Pennsylvania experiences overlapping burdens of PFAS exposure and cardiovascular disease."
PFAS contamination is a public health concern because these chemicals can remain in the environment for long periods and reach people. Some PFAS accumulate in the body, and repeated exposure may increase the amount present over time.
The National Institutes of Health identifies several health concerns linked with exposure to certain PFAS, including immune system effects, increased cholesterol, liver changes, pregnancy-related complications and some cancers.
The US Environmental Protection Agency has established legally enforceable drinking water limits for six PFAS compounds, including perfluorooctanoic acid (PFOA) and perfluorooctanesulfonic acid (PFOS).
Researchers say more comprehensive monitoring, better assessment and long-term epidemiological studies are needed to understand how PFAS contamination affects communities.
Credit: iStock
A simple five-factor risk score may help identify people at high risk of dementia, particularly in low- and middle-income countries (LMICs), where around 60% of the world's dementia cases now occur.
Developed and validated by researchers at Northumbria University, the risk score uses five everyday factors to identify older adults at higher risk of dementia. It aims to address a gap in dementia research, as existing prediction tools have largely been developed using data from high-income countries and may not work as well in lower-income settings.
The research team developed the model using data from more than 11,000 older adults across seven countries and three continents.
“We know the burden of dementia is shifting towards lower-income parts of the world, yet the prediction models clinicians and researchers rely on were designed with wealthier populations in mind. This model is a step towards changing that. It is simple, it is built for the settings where it is needed most, and it gives researchers a practical way to find the people who should be the focus of future studies and trials,” said Dr Eduwin Pakpahan, from Northumbria University's Applied Statistics and Data Science Research Group. The study is published in the American Journal of Epidemiology.
Also read: WHO's New Dementia Guidelines Prioritize Healthy Habits, Warn Against Supplements
The model can be applied using information gathered through a straightforward conversation with an older adult and, where relevant, a family member or carer. It does not require blood tests, brain scans or specialist equipment.
The five factors included in the risk score are:
Each factor contributes points towards a total score ranging from 0 to 9. A person scoring 0 has around a 1% chance of developing dementia within three years, while someone scoring 9 has a nearly 19% chance.
The researchers built and tested the model across seven sites in China, Cuba, the Dominican Republic, Puerto Rico, Venezuela, Mexico and Peru. It achieved a performance score of 0.75, above the 0.70 threshold generally regarded as clinically useful.
However, the researchers emphasise that the tool is primarily intended for research rather than routine screening of the general population. It could give researchers and clinical trial teams a practical, low-cost way to identify and recruit people at higher risk of dementia.
The team has also called for the model to be validated in regions not covered by the study, particularly South Asia, the Middle East and North Africa, and Sub-Saharan Africa.
Read More: Dementia Is More Than Forgotten Birthdays, Lost Keys: Doctors Explain Early Signs Before Memory Loss
Dementia affects more than 57 million people worldwide, with around 60% of cases occurring in LMICs across Latin America, the Caribbean, Asia and Africa.
Identifying people at higher risk could help researchers in these regions plan studies and clinical trials that better reflect their populations. A simple tool based on everyday information may also make risk assessment more accessible in settings where specialised diagnostic resources are limited.
© $2026 Times Horizon Private Limited